Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Uveal Melanoma × Diet Therapy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Smoking Cessation 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Multiple Myeloma 1 Motor Activity 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammation 1

Interventions

Ipilimumab 9 pembrolizumab 6 incomplete Freund's adjuvant 6 Nivolumab 6 Dacarbazine 5 Temozolomide 4 Sunitinib 4 MART-1 Antigen 4 tebentafusp 3 sargramostim 3 montanide ISA 51 3 aflibercept 3 Paclitaxel 3 Carboplatin 3 CTLA-4 Antigen 3 Bevacizumab 3 trametinib 2 olaparib 2 lenvatinib 2 cediranib 2 Vorinostat 2 Taxes 2 Sorafenib 2 Radiosurgery 2 MAGEA3 protein, human 2 Lenalidomide 2 Interleukin-2 2 Interleukin-12 Subunit p35 2 Cyclophosphamide 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04645680 2026-01-30

DIET

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡